Use of SH2 STAT3/STAT1 Peptidomimetics as Anticancer Drugs

The subject invention concerns compositions and methods for blocking cancer cell growth or proliferation and/or inducing cancer cell death. Compositions of the present invention are peptidomimetics that inhibit STAT function. Peptidomimetics of the invention display selective inhibition of specific STAT isoform homo-dimerization. The peptidomimetic probes of STAT1 function, described herein, provide the means to preferentially inhibit STAT1 over STAT3 through the exploration of the C-terminus.

Attached files:
US 20090318367.jpg

Patents:
US 20,090,318,367

Inventor(s): SEBTI SAID M [US]; HAMILTON ANDREW D [US]; TURKSON JAMES [US]; JOVE RICHARD [US]

Type of Offer: Sale



Next Patent »
« More Life Sciences Patents

Share on      


CrowdSell Your Patent